CACNA2D2 and epilepsy: Recent evidence suggests that the effects of CACNA2D2 on axonal growth and elongation as well as on synaptic formation are inhibited by pregabalin, a drug which targets the α2δ-2 subunit and which is used in several neurological conditions, including epilepsy (Tedeschi et al., 2016).